Norepinephrine-evoked pain in fibromyalgia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN70707830

Enrollment

Registered

2002-01-15

Start date

2000-01-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia Musculoskeletal Diseases Soft tissue disorders

Interventions

1. Subcutaneous injection of 10 micrograms of norepinephrine diluted in 0.1 ml normal saline solution 2. Subcutaneous injection of 0.1 ml normal saline

Eligibility

Inclusion criteria

Inclusion criteria: 1. 20 patients with fibromyalgia 2. 20 patients with rheumatoid arthritis 3. 20 normal controls

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
Not provided at time of registration	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

Mexico

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026